Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

In vitro differentiation of osteocytes and adipocytes from human placenta-derived cells.

Sun NZ., Ji H.

Laboratory Study on Face & Skin, published in J Int Med Res (2012) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
J Int Med Res (2012)
Country
England
Reported sample size
—
Source database
PubMed
PMID
22613441
DOI
10.1177/147323001204000242

Abstract (original English)

To investigate the capability of human placenta-derived adherent cells to differentiate into osteocytes and adipocytes. Placenta-derived adherent cells were isolated by type IV collagenase digestion of a single freshly obtained human placenta and cultured under standard conditions. Cell surface markers of adherent cells from passages 3 - 9 were analysed by flow cytometry. Osteocytic differentiation was induced with β-glycerol phosphate, vitamin C and dexamethasone and confirmed by Alizarin red staining. Adipocytic differentiation was induced with dexamethasone and insulin and confirmed by oil red O staining. Placenta-derived adherent cells were positive for high levels of CD44 and CD105 and very low levels of CD29 but were negative for CD34, CD45 and CD19. This pattern of cell surface markers is identical to human mesenchymal stem cells. Alizarin red-positive cells were detected 10 days after the induction of osteocyte differentiation. Oil red O-positive cells were detected 7 days after the induction of adipocyte differentiation. Placenta-derived adherent cells can differentiate into either osteocytes or adipocytes in vitro. The human placenta may provide an alternative source of mesenchymal stem cells for basic research and clinical use.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdipogenesisAntigens, CDAntigens, CD19Antigens, CD34Ascorbic AcidCell DifferentiationCells, CulturedDexamethasoneEndoglin

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research